$ESPR Esperion Therapeutics (NASDAQ:ESPR) Price Target Raised to $5.00 marketbeat.com/instant-alerts…
English
Brinks Private Wealth Fund. 5 years Up 280%
2.1K posts
Brinks Private Wealth Fund. 5 years Up 280%
@Brinkswealth10
Current Holdings ESPR, IREN, COST, SOFI, NNDM, BITF, CORZ, RIG,SPY, SGOV
Italy Katılım Ekim 2019
175 Takip Edilen4.8K Takipçiler
$ESPR HUGE , The Guidelines updated next week CONFIRMED. Buy as much ESPR stock today . #STOCKTOBUY Citizens analyst raised his price target today to $5 for 2026 from $4. HCW analyst has $16 and Piper & Cantor have $9 Price Targets. ESPR stock just $2.41 now. was $4.18 Jan
English
$ESPR Esperions #drugs #NEXLIZET & #NEXLETOL are the ONLY #statinalternative drugs to lower HSCRP and by #HUGE 46% . #TOP #Analysts have see serious #growth Price Targets $5 $9 $9 $16 . #BIGPHARMA #TAKEOVER
Brighteyes2071@sigmatrader9
$ESPR CEO Talking We are the only #Statin alternative to lower #hscrp & we do by 46% . #AMAZING #StockslnFocus
English
$ESPR HUGE #NEWS expected soon. #Esperion #prescription #demand going to #explode #HIGHER #StockslnFocus #shortsqueeze 42 MILLION SHARES SHORT
Brighteyes2071@sigmatrader9
$ESPR HUGE Guidelines boost on Drugs NEXLIZET (Bempedoic acid & EZETIMIBE) & NEXLETOL out any day. #StockslnFocus #StocksToTrade #stocksToBuy
English
$ESPR Cheapest stock to own based on the #huge #growth this company is starting to see. #stocktobuy #jasonbutler #analyst #citizensbank
Brighteyes2071@sigmatrader9
$ESPR Growing cash, soon profitable. $2.59 is a great buying opportunity. Listen to the CFO. This will be a $6 stock this year. Analysts have price target average of $9.
English
$ESPR This ESPR Stock is crazy undervalued. #BUY as much as you can. This will be a $25 stock in 5 years or less.
Brighteyes2071@sigmatrader9
$ESPR Esperion partners are selling #NEXLIZET & #NEXLETOL are rapid growth.
English
$ESPR Attention CEO & CFO . Start Tweeting and sharing the highlights about what was said today. I will re share it and my contacts over seas will start buying the stock like crazy. Just you see. $2.61 is a Joke . The shorts are attacking this company. #stoptheshorts
English
$ESPR $2.67 Amazing bargain now. If you buy some today you will be greatly rewarded. I am actually going to be buying more myself next week. I am wiring in funds. $SPY $QQQ The guidelines news is going to be very, very BIG and is expected any day. #StockToWatch #stocks
English
$ESPR BUY as much as you can. Guidelines News likely out Tomorrow says Expert in the field. #SHORTSQUEEZE #StocksToBuy #StockToWatch
English
Two Stocks to BUY Today: $IBRX Interesting name and could run-up next week. Tonight on FOX News Nation. $ESPR BIG News expected next week.
English
$ESPR Profitable this year with massive royalty revenue ramping. Patent protection locked in through 2040.
Trading at a huge discount to top analyst price targets (~$9/share).
The setup for Esperion Therapeutics keeps getting stronger. @EsperionInc #StocksToWatch #STOCKTOBUY
English
$ESPR My #1 holding
> Esperion is projected to earn ~$450M in royalties by 2029 from partners alone.
> Apply a 20x P/E → ~$9B market cap.
> That **excludes U.S. sales**.
> $ESPR at $20+ looks very achievable. 📈
English
$ESPR Guidelines news expected VERY soon.
English
$ESPR The current stock price is absurdly cheap $2.93. Last week we had several analysts repeat BUY RATINGS $9 price targets. I would think Goldman Sachs comes in with a bullish note soon. Profitable, trading below $5 is a bargain. #stocksToBuy #StocksInFocus #StocksToWatch
English
$ESPR This stock dropped on Q4 Revenue being light. That had to pay a large ONE time amount in Medicare & Medicaid. ESPR will be profitable this year, $7 year end target. $20+ by 2028. REAL GROWTH STORY. #BUYINGMORE #NOW #StocksToBuy #OVERSOLD
English
$GRRR #StocksToWatch #StocksToTrade #StockslnFocus #shortsqueeze #stockstobuy tipranks.com/news/the-fly/g…
Brinks Private Wealth Fund. 5 years Up 280%@Brinkswealth10
$GRRR Stock $11.33. Richard says Cantor Fitzgerald which started GRRR at Overweight (StrongBuy) with a $31 Price target on 12/11 verified GRRR contracts, will earn 30c profit for Q4. Richard says this company is highly undervalued. Forward P/E under 12 x 2026 Earnings
QME
$GRRR Stock $11.33. Richard says Cantor Fitzgerald which started GRRR at Overweight (StrongBuy) with a $31 Price target on 12/11 verified GRRR contracts, will earn 30c profit for Q4. Richard says this company is highly undervalued. Forward P/E under 12 x 2026 Earnings
English
@MACROVET888 i have been expecting a take over offer for sometime, who knows, guess we just have to see.
English
@Brinkswealth10 will not be independent in 2027...after ANDAs' settlement and new U.S guidelines ... Vultures will be around! IMO
English
$ESPR “Great job, David! Just wrapped up an excellent Piper Sandler event. Now officially on the Kaiser formulary.
Forecasts: $9 next year, $15 in 2027, $28 in 2029.
Personally, I steer clear of statins—Nexlizet has been a lifesaver for me.” #NEXLIZET Best LDL lowering drug,
English